Table: Jcr Pharmaceuticals -2021/22 parent results

JCR Pharmaceuticals

12/05/2022 08:00

May 12 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             51.08           30.09                                
                 (+69.8 pct)     (+21.7 pct)                             
  Operating         20.14            8.64                                
                (+133.0 pct)    (+162.8 pct)                             
  Recurring         20.43            8.59                                
                (+137.7 pct)    (+157.1 pct)                             
  Net               14.45            7.08                                
                (+104.0 pct)    (+158.3 pct)                             
  EPS            116.77 yen       57.33 yen                              
  EPS Diluted    116.31 yen       57.05 yen                              
  Ann Div         22.00 yen                      20.00 yen               
  -Q2 Div         10.00 yen       18.00 yen      10.00 yen               
  -Q4 Div         12.00 yen       7.50 yen       10.00 yen               
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T